Teva Pharmaceuticals Acquires Labrys Biologics
Teva Pharmaceuticals acquired Labrys Biologics for $825.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Teva Pharmaceuticals
- Acquired Company
- Labrys Biologics
- Price
- $825.0M
- Acquisition Type
- Acquisition
- Announced
- June 3, 2014
Canonical: https://fsome.com/acquisitions/teva-pharmaceuticals-acquires-labrys-biologics-8047340 · For the full deal terms, timeline, and press references, please enable JavaScript.